1. Warburg O. On the origin of cancer cells. Science 1956;123:309–14
2. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S–93S
3. Kubota K, Ishiwata K, Kubota R, Yamada S, Tada M, Sato T, et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18- fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. J Nucl Med 1991;32:2118–23
4. Yoshioka T, Takahashi H, Oikawa H, Maeda S, Ido T, Akaizawa T, et al. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice. J Nucl Med 1997;38:714–7
5. Kostakoglu L, Goldsmith SJ. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003;44:224–39